Life sciences accelerator launches to bolster UK innovation

Alderley Park

A new accelerator programme at Alderley Park has been launched to support innovation and growth in the region.

Bruntwood SciTech’s Life Science Accelerator programme has been designed to cater to the unique needs of early-stage life science companies from across the UK, offering comprehensive support and specialist facilities to fuel their growth and development.

Successful applicants will receive personalised support aimed at accelerating their idea from lab through to commercialisation. The six-month programme will combine specialist laboratory incubation support and business model development, with expertise provided by a range of industry leaders.

Up to 10 early-stage life sciences companies will get the chance to receive dedicated expertise and support valued at around £60,000.

Across the six months, participating biotech entrepreneurs will receive complimentary laboratory access, supplemented by access to pay-per-use scientific equipment via the Open Access Lab, which equates to over £20,000 worth of laboratory support and kit access. Aspects of the programme will see companies work with experts to develop comprehensive commercialisation plans for areas including market space definition, proposition framing, customer definition, distribution, marketing and sales, IP management, and funding.

Support for laboratory equipment will also be provided and recipients will receive £10,000 in flexible financial support, enabling them to invest in essential laboratory supplies or professional advice.

The launch follows Bruntwood SciTech’s recent investment in a £60 ($75.1) million development in Manchester intended to enhance the city’s Oxford Road Corridor knowledge quarter as a hub for life sciences and technology innovation.

Supporting early-stage life science companies

The project is being funded by the UK Government through the UK Shared Prosperity Fund, aligning with Bruntwood SciTech’s commitment to driving growth and knowledge sharing in the region. The UK Shared Prosperity Fund has committed £2.6 billion to local investment by March 2025 and is part of the government’s Levelling Up agenda.

Dr Kath Mackay, Chief Scientific Officer at Bruntwood SciTech said: “The new Life Science Accelerator programme truly embodies our dedication to supporting early-stage life science companies across the UK by providing them with the necessary resources and guidance to thrive. Our mission is to empower these companies to bring their innovative ideas to fruition, ultimately contributing to the advancement of the life sciences sector and the broader economy.

“Launching this programme at Alderley Park allows participants to tap into the vibrant ecosystem of scientific companies and foster valuable networking opportunities, enriching the community and driving further collaboration.”

Image credit: Bruntwood SciTech

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free